Gore: New Innovations Include Steerable Sheath at VEITHsymposium
W. L. Gore & Associates plans to present clinical evidence on aortic and venous treatments and introduce a steerable sheath at VEITHsymposium in New York City. The meeting runs Nov. 17-21, with presentations covering patient outcomes and procedures using Gore devices.
W. L. Gore & Associates’ medical business will present new innovations in vascular care and introduce a steerable sheath at VEITHsymposium in New York City, scheduled for Nov. 17-21, 2026. The program will include clinical evidence on aortic repair and deep venous disease.
The company plans to debut the GORE GUIDRA Steerable Sheath, designed to help physicians access blood vessels and deliver diagnostic or treatment devices during complex endovascular procedures. Its initial launch will feature a 12 Fr size, with additional sizes planned for 2027.
Gore Americas Business Leader Jason Belzer said the company would present recent developments across its vascular portfolio. These include an expanded U.S. indication for the GORE VIABAHN VBX Balloon Expandable Endoprosthesis and the launch of the GORE VIABAHN FORTEGRA Venous Stent.
A Gore-sponsored symposium on Nov. 19 will examine three-year clinical outcomes from the EMBRACE Registry. Luca Bertoglio, M.D., and Gustavo S. Oderich, M.D., are scheduled to discuss use of the VBX Stent Graft as a bridging stent graft in fenestrated and branched endovascular aortic repair.
The device recently received U.S. Food and Drug Administration approval for an expanded indication, Gore said. The symposium is set to consider clinical lessons from the registry data and their relevance to complex aortic care.
Professor Stephen Black will present one-year outcomes from a 112-patient clinical study of the FORTEGRA Venous Stent on Nov. 20. The prospective, international, multicenter study focuses on patients with symptomatic obstruction of the inferior vena cava.
Earlier one-year results from an initial 89-patient cohort were published in the European Journal of Vascular and Endovascular Surgery. Black and Kathleen Gibson, M.D., are also scheduled to discuss the development of venous stenting at a Gore-sponsored symposium.
Thoracoabdominal aortic repair will feature in a Nov. 17 lunch symposium. Jason Lee, M.D., and Shahab Toursavadkohi, M.D., will discuss best practices using the GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis and newly published 30-day outcomes from its post-approval study.
Nimesh D. Desai, M.D., Ph.D., is scheduled to discuss open surgical Zone 2 arch repair using a sequential TEVAR approach and the GORE TAG Thoracic Branch Endoprosthesis at a Gore-sponsored symposium on Nov. 18.
